Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001172661-24-001208
Filing Date
2024-02-14
Accepted
2024-02-14 14:10:03
Documents
1

Document Format Files

Seq Description Document Type Size
1 rocksprings-inzy123123a2.htm SC 13G/A 110267
  Complete submission text file 0001172661-24-001208.txt   111973
Mailing Address 650 SOUTH EXETER STREET SUITE 1070 BALTIMORE MD 21202
Business Address 650 SOUTH EXETER STREET SUITE 1070 BALTIMORE MD 21202 4102200129
Rock Springs Capital Management LP (Filed by) CIK: 0001595725 (see all company filings)

EIN.: 800944416 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 321 SUMMER STREET SUITE 400 BOSTON MA 02210
Business Address 321 SUMMER STREET SUITE 400 BOSTON MA 02210 857-330-4340
Inozyme Pharma, Inc. (Subject) CIK: 0001693011 (see all company filings)

EIN.: 475129768 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91586 | Film No.: 24635934
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)